In recognition of efforts made in cancer therapeutic research, Joseph R. Bertino, MD, chief scientific officer at The Cancer Institute of New Jersey (CINJ), has been honored with The Jeffrey A. Gottlieb Memorial Award sponsored by The University of Texas MD Anderson Cancer Center. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
The Jeffrey A. Gottlieb Memorial Award, established in 1975, recognizes physicians and scientists who have made outstanding contributions to cancer therapeutic research. The award was created to honor the memory of Dr. Jeffrey A. Gottlieb, who made exceptional advances in the field of chemotherapy before losing his personal battle with cancer in 1975.
Dr. Bertino, a university professor of medicine and pharmacology at UMDNJ-Robert Wood Johnson Medical School, is the author or co-author of more than 400 scientific publications. He is currently leading his laboratory in developing new treatments for patients with cancer, and in particular, drugs that specifically target tumor stem cells.
Engineered SNIPRs transform CAR T-cell precision for safer cancer therapy